Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC to Provide Insight Into Small Molecule Targeting of BCL6

ACS Chemical Biology - United States
doi 10.1021/acschembio.8b00698
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

B-Cell CLL/lymphoma 6 (BCL6); Heat Shock Protein 90 (Hsp90)

Science-Business eXchange
2009English

Small-Molecule Kinase Inhibitors Provide Insight Into Mps1 Cell Cycle Function

Nature Chemical Biology
Cell BiologyMolecular Biology
2010English

Novel BCL6 Inhibitor (FX1): Advances in Diffuse Large B-Cell Lymphomas (DLBCLs) Treatment

Biomedical Sciences
2017English

RETRACTED ARTICLE: Primary Central Nervous System High-Grade B-Cell Lymphoma, With Rearrangements of MYC and BCL6

Baylor University Medical Center Proceedings
Medicine
2018English

BCL6-Driven Lymphoma Is Dependent on LSD1 Corepression

Cancer Discovery
Oncology
2018English

Rationale for Targeting BCL6 in MLL-rearranged Acute Lymphoblastic Leukemia

Genes and Development
GeneticsDevelopmental Biology
2019English

BCL6 Gene Mutations in Transitional Cell Carcinomas

Journal of International Medical Research
BiochemistryMedicineCell Biology
2007English

Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight Into Mechanisms of Chemokine Receptor Activation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Evi9 Encodes a Novel Zinc Finger Protein That Physically Interacts With BCL6, a Known Human B-Cell Proto-Oncogene Product

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy